Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

11 trials with published results (15%)

Research Maturity

51 completed trials (71% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.2%

3 terminated out of 72 trials

Success Rate

94.4%

+7.9% vs benchmark

Late-Stage Pipeline

7%

5 trials in Phase 3/4

Results Transparency

22%

11 of 51 completed with results

Key Signals

11 with results94% success

Data Visualizations

Phase Distribution

44Total
Not Applicable (28)
P 1 (6)
P 2 (5)
P 3 (2)
P 4 (3)

Trial Status

Completed51
Unknown11
Recruiting5
Terminated3
Active Not Recruiting2

Trial Success Rate

94.4%

Benchmark: 86.5%

Based on 51 completed trials

Clinical Trials (72)

Showing 20 of 20 trials
NCT06519994Phase 2Completed

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

NCT05026138RecruitingPrimary

Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)

NCT04708470Phase 1Active Not Recruiting

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

NCT07418203CompletedPrimary

Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination

NCT05413811Not ApplicableCompleted

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

NCT06582004Not ApplicableActive Not Recruiting

Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1

NCT06434337RecruitingPrimary

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

NCT05672927Phase 4Recruiting

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

NCT02236273Not ApplicableCompletedPrimary

Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents

NCT05365048Not ApplicableRecruitingPrimary

Provider Recommendation and HPV Vaccination

NCT04901351Not ApplicableRecruitingPrimary

Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology

NCT04746872CompletedPrimary

Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

NCT05931354Unknown

Longitudinal HPV Pap in CIN and VAIN

NCT02622997Not ApplicableCompletedPrimary

Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples

NCT02740790Phase 2CompletedPrimary

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

NCT02740777Phase 2CompletedPrimary

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

NCT00786760CompletedPrimary

Natural History of HPV Infection in Men: The HIM Study

NCT02651883Not ApplicableCompleted

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

NCT03000933CompletedPrimary

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

NCT02503111Not ApplicableTerminated

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Scroll to load more

Research Network

Activity Timeline